Hemodynamic and Rhythmologic Effects of Push-Dose Landiolol in Critical Care-A Retrospective Cross-Sectional Study
<span style="text-decoration: underline;">Background:</span> The highly β1-selective beta-blocker Landiolol is known to facilitate efficient and safe rate control in non-compensatory tachycardia or dysrhythmia when administered continuously. However, efficacy and safety data of...
Saved in:
Main Authors: | Sebastian Schnaubelt (Author), Felix Eibensteiner (Author), Julia Oppenauer (Author), Daniel Tihanyi (Author), Marco Neymayer (Author), Roman Brock (Author), Andrea Kornfehl (Author), Christoph Veigl (Author), Valentin Al Jalali (Author), Sonja Anders (Author), Barbara Steinlechner (Author), Hans Domanovits (Author), Patrick Sulzgruber (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of Chronic Oral Beta-Blocker Intake on Intravenous Bolus Landiolol Response in Hospitalized Intensive Care Patients with Sudden-Onset Supraventricular Tachycardia-A Post Hoc Analysis of a Cross-Sectional Trial
by: Felix Eibensteiner, et al.
Published: (2024) -
Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease
by: Kunisawa T, et al.
Published: (2015) -
Direct Effects of Esmolol and Landiolol on Cardiac Function, Coronary Vasoactivity, and Ventricular Electrophysiology in Guinea-Pig Hearts
by: Shigehiro Shibata, et al.
Published: (2012) -
An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation
by: Mariana Floria, et al.
Published: (2024) -
Pushed and the Return Push
by: Nichols, George Herbert Fosdike